Healthcare News and Headlines

China Startup CirCode Gets Clearance for Trial of Circular RNA Therapy
NewsMar 16, 2026

China Startup CirCode Gets Clearance for Trial of Circular RNA Therapy

Cir‑Code Bio‑med, a Chinese biotech focused on circular RNA medicines, has secured an Investigational New Drug (IND) approval from the U.S. Food and Drug Administration to commence its first human trial. The therapy targets a rare genetic disorder using a...

By Endpoints News
Here’s How Physicians Can Better Treat Thyroid Issues
NewsMar 16, 2026

Here’s How Physicians Can Better Treat Thyroid Issues

Physicians are adopting minimally invasive tools like radiofrequency ablation (RFA) to treat benign thyroid nodules, reducing the need for surgery and preserving gland function. Enhanced diagnostics—including high‑resolution ultrasound and comprehensive hormone panels—are improving accuracy and enabling data‑driven treatment adjustments. Integrating...

By Healthcare Guys
Oxford Medical Simulation Secures €5.78 Million to Tackle Healthcare Training Gap with Virtual Reality
NewsMar 16, 2026

Oxford Medical Simulation Secures €5.78 Million to Tackle Healthcare Training Gap with Virtual Reality

Oxford Medical Simulation (OMS) has secured €5.78 million in growth funding from Salica Investments. The capital will fund OMS’s expansion into U.S. health systems and universities, and accelerate product innovation such as AI‑driven scenarios, learning analytics, and workflow tools. The round...

By EU-Startups
What’s at Stake for Bayer in Its Supreme Court Showdown?
NewsMar 16, 2026

What’s at Stake for Bayer in Its Supreme Court Showdown?

Bayer’s 2018 acquisition of Monsanto brought a wave of glyphosate lawsuits, prompting a proposed $7.25 billion class settlement and an undisclosed additional pact. The company’s CEO, Bill Anderson, is steering a restructuring that includes 12,000 layoffs and a focus on pharma...

By PharmaVoice
Re: Abu-Sitta Case: New Regulator Joins Appeal Effort on Doctor Cleared of Supporting Terrorism
NewsMar 16, 2026

Re: Abu-Sitta Case: New Regulator Joins Appeal Effort on Doctor Cleared of Supporting Terrorism

The Professional Standards Authority has announced it will support the General Medical Council’s appeal of the Medical Practitioners Tribunal Service’s decision that cleared Dr Ghassan Abu‑Sitta of terrorism‑related misconduct. The appeal follows a petition signed by thousands of doctors demanding the...

By BMJ (Latest)
STAT+: Structure Therapeutics Reports Significant Weight Loss From Mid-Stage GLP-1 Pill
NewsMar 16, 2026

STAT+: Structure Therapeutics Reports Significant Weight Loss From Mid-Stage GLP-1 Pill

Structure Therapeutics announced that its daily oral GLP‑1 obesity pill produced an average 16% body‑weight reduction versus placebo after 44 weeks in a Phase 2 trial. The result outperforms Eli Lilly’s orforglipron, which showed about 11% loss over 72 weeks, and rivals...

By STAT (Biotech)
Havas Life London Identifies Stigma as a Structural Barrier in Rare Disease
NewsMar 16, 2026

Havas Life London Identifies Stigma as a Structural Barrier in Rare Disease

Havas Life London’s new report reveals that stigma is a pervasive, structural barrier in rare disease care, affecting 89% of patients and caregivers surveyed. Healthcare settings account for the largest share of stigma incidents, with 42% reporting dismissed symptoms and...

By PharmaLive
Structure Therapeutics Reports More Phase 2 Data for Oral GLP-1
NewsMar 16, 2026

Structure Therapeutics Reports More Phase 2 Data for Oral GLP-1

Structure Therapeutics released Phase 2 data for its oral GLP‑1 agonist, positioning the candidate as a next‑generation alternative to injectable therapies from Eli Lilly and Novo Nordisk. The trial demonstrated a mean 30% reduction in HbA1c and 70% of participants achieving target...

By Endpoints News
The Peptide Boom Is Getting Out of Hand
NewsMar 16, 2026

The Peptide Boom Is Getting Out of Hand

The Atlantic outlines a surge in off‑label and experimental peptide use, noting that Vyleesi—approved for women’s hypoactive sexual desire disorder—is being bought by men through “research use only” listings and online pharmacies. Compounding pharmacies and telehealth firms now market customized...

By The Atlantic (Health)
‘Compensation Remodeling’ and 9 Other Solutions to Help Preserve Radiology’s Core Mission
NewsMar 16, 2026

‘Compensation Remodeling’ and 9 Other Solutions to Help Preserve Radiology’s Core Mission

The American College of Radiology’s 2025 Intersociety Meeting produced ten actionable solutions to halt the erosion of academic radiology’s core mission of patient care, education, and research. Experts cite practice consolidation, rising imaging volumes and burnout as primary threats. Recommendations...

By Radiology Business
Widespread US Shift From Prescription to OTC Lies in Pharma’s Hands
NewsMar 16, 2026

Widespread US Shift From Prescription to OTC Lies in Pharma’s Hands

The FDA is accelerating the shift of prescription medicines to over‑the‑counter status, highlighted by Commissioner Marty Makary’s call for broader OTC availability and the introduction of the Additional Condition for Non‑Prescription Use (ACNU) framework. Former FDA counsel Heidi Gertner stresses...

By Pharmaceutical Technology (GlobalData)
Family Caregivers’ Needs in Late-Stage Dementia
NewsMar 16, 2026

Family Caregivers’ Needs in Late-Stage Dementia

A new qualitative study in BMC Geriatrics reveals the intense psychological, physical, and social pressures faced by family caregivers of late‑stage dementia patients. Interviews expose high rates of depression, anxiety, and burnout, compounded by fragmented health‑care navigation and dwindling social...

By Bioengineer.org
“Mad Scientist” Mike Schultz Has Created Prosthetics for Para Snowboarders That Often Beat Him
NewsMar 16, 2026

“Mad Scientist” Mike Schultz Has Created Prosthetics for Para Snowboarders That Often Beat Him

Mike Schultz retired from Paralympic snowboarding after winning a bronze in the Cortina banked slalom, capping a career that includes four medals and two golds. He is celebrated for designing the BioDapt prosthetic knee and foot that now equip every...

By Powder
After Novartis Pact, Macrocycle Shop Unnatural Products Gets $45M Series B
NewsMar 16, 2026

After Novartis Pact, Macrocycle Shop Unnatural Products Gets $45M Series B

Santa Cruz‑based Unnatural Products secured a $45 million Series B round to accelerate its macrocycle drug platform. The financing follows a newly announced partnership with Novartis that will grant the pharma giant early access to the company’s pipeline and a co‑development option...

By Endpoints News
Officials ‘Missed 99% of Data’ on Covid Vaccines Before Making Recommendation, Memos Reveal
NewsMar 16, 2026

Officials ‘Missed 99% of Data’ on Covid Vaccines Before Making Recommendation, Memos Reveal

Internal HHS memos released in a lawsuit reveal officials ignored about 99% of available safety and efficacy data when deciding to end COVID‑19 vaccine recommendations for pregnant people and children. The decision was announced by HHS Secretary Robert F. Kennedy...

By The Guardian – Science
Hospital Apologizes After Leaving Patient on MRI Scanner for 6 Hours
NewsMar 16, 2026

Hospital Apologizes After Leaving Patient on MRI Scanner for 6 Hours

Tongji Hospital in Wuhan apologized after a patient was left inside an MRI scanner for nearly six hours due to a failed shift‑handover. The attending physician marked the exam complete at 12:10 a.m., but the patient remained immobile until cleaning staff...

By Radiology Business
Understanding CDSCO Import Licensing: A 2026 Guide for Medical Device Manufacturers
NewsMar 16, 2026

Understanding CDSCO Import Licensing: A 2026 Guide for Medical Device Manufacturers

India’s medical‑device market now requires every imported device to secure a CDSCO import licence through the SUGAM portal, regardless of risk class. Manufacturers must first classify the product under the 2017 Medical Device Rules, appoint an Indian Authorized Agent, and...

By Healthcare Guys
Bayer Reports the P-III (FIND-CKD) Trial Data on Kerendia in Non-Diabetic Chronic Kidney Disease
NewsMar 16, 2026

Bayer Reports the P-III (FIND-CKD) Trial Data on Kerendia in Non-Diabetic Chronic Kidney Disease

Bayer disclosed results from the pivotal Phase III FIND‑CKD trial evaluating Kerendia (finerenone) in more than 1,500 adults with non‑diabetic chronic kidney disease. Patients received 10 mg or 20 mg of Kerendia alongside standard of care and were compared with placebo. The study...

By PharmaShots
Industry Innovators to Reveal High-Performance Strategies at 31st Annual Executive War College
NewsMar 16, 2026

Industry Innovators to Reveal High-Performance Strategies at 31st Annual Executive War College

The 31st Annual Executive War College will convene April 28‑29 in New Orleans, spotlighting early‑adopter labs tackling reimbursement pressure, workforce shortages, and new regulations. Speakers include MD Anderson’s Walter McAndrew on molecular workflow cost cuts, Abbott’s Jonathan Burgart on turning excess capacity...

By Dark Daily
Staff Cuts Hit 9/11 WTC Health Program as Workers Reassigned to ICE
NewsMar 16, 2026

Staff Cuts Hit 9/11 WTC Health Program as Workers Reassigned to ICE

Federal officials have reassigned two senior employees of the World Trade Center Health Program to Immigration and Customs Enforcement and the Indian Health Service, deepening an already severe staffing shortage. The program, budgeted for 120 workers, now operates with only...

By EMS1 – News
KORU Medical Secures Certification Under EU MDR for Infusion Pump
NewsMar 16, 2026

KORU Medical Secures Certification Under EU MDR for Infusion Pump

KORU Medical has obtained European Union Medical Devices Regulation (EU MDR) certification for its Freedom60 infusion pump, which includes an adapter for 50 ml prefilled syringes, allowing commercialisation across the EU. The pump complements the FreedomEDGE system that supports 20 ml cartridges,...

By Hospital Management
J&J Reports Positive Data for Erda-iDRS in Bladder Cancer
NewsMar 16, 2026

J&J Reports Positive Data for Erda-iDRS in Bladder Cancer

Johnson & Johnson announced encouraging Phase I data for its intravesical drug‑releasing system Erda‑iDRS in non‑muscle‑invasive bladder cancer (NMIBC) with FGFR alterations. The trial met its primary safety endpoint and delivered an 89% complete response rate in intermediate‑risk patients, with responses...

By Hospital Management
Restless Legs Syndrome Risk Higher in People with Multiple Sclerosis, Study Finds
NewsMar 16, 2026

Restless Legs Syndrome Risk Higher in People with Multiple Sclerosis, Study Finds

A Spanish study of 440 MS patients and 241 matched controls found restless legs syndrome (RLS) twice as common in MS. Confirmed RLS prevalence was 15.2% among MS patients versus 7.9% in controls. Pyramidal symptoms and family history raised RLS...

By ACNR (Advances in Clinical Neuroscience & Rehabilitation)
Kistler and ATS Develop High-Speed Medical Device Assembly Line with Real-Time Quality Monitoring
NewsMar 16, 2026

Kistler and ATS Develop High-Speed Medical Device Assembly Line with Real-Time Quality Monitoring

Kistler Group and ATS Life Sciences Systems have launched the Symphoni platform, a high‑speed medical device assembly line capable of processing up to 320 parts per minute while cutting tooling requirements by 90 percent. The system combines Kistler’s force and displacement...

By Robotics & Automation News
Spotlight Pathology Secures £1.4 Million Seed Investment for AI Blood Cancer Diagnostics
NewsMar 16, 2026

Spotlight Pathology Secures £1.4 Million Seed Investment for AI Blood Cancer Diagnostics

Liverpool‑based Spotlight Pathology has closed a £1.4 million seed round to accelerate its AI‑driven blood cancer diagnostic platform. The round was co‑led by the UK Innovation and Science Seed Fund and the Liverpool City Region Seed Fund, earmarked for product development,...

By HTN – Health Tech Newspaper (UK)
As Parents Clamor for a Treatment Touted for Autism, Doctors Hesitate to Prescribe It
NewsMar 16, 2026

As Parents Clamor for a Treatment Touted for Autism, Doctors Hesitate to Prescribe It

Federal officials promoted leucovorin, a vitamin B9 derivative, as a potential autism treatment, prompting a surge in parental demand and online communities. The FDA later clarified that the drug is only approved for the ultra‑rare FOLR1‑related cerebral folate deficiency, not...

By NPR (Health)
Access to Mental Health Treatment Services in Asian Languages
NewsMar 16, 2026

Access to Mental Health Treatment Services in Asian Languages

Asian language speakers with limited English proficiency face major barriers to mental‑health care in the United States. A new cross‑sectional study of 3,847 facilities from 2015‑2024 found that only 5.6 % offered services in an Asian language in 2024, down from...

By RAND Blog/Analysis
Healthcare Tech Innovation: Lessons From HIMSS 2026
NewsMar 16, 2026

Healthcare Tech Innovation: Lessons From HIMSS 2026

Healthcare leaders at HIMSS 2026 highlighted how moving Epic to AWS has become a mainstream strategy, now adopted by over 50 systems across North America and Australia. The cloud foundation enabled Jupiter Medical Center to slash radiology‑scheduling backlogs by 60% and...

By Healthcare Dive (Industry Dive)
Medicaid Expansion for La Comunidad Latina in North Carolina
NewsMar 16, 2026

Medicaid Expansion for La Comunidad Latina in North Carolina

The FIEL‑NC project examined Medicaid enrollment among North Carolina’s Latino community after the state’s expansion. Of 44 surveyed community members, 30% successfully enrolled, 36% attempted but were denied, and 34% did not try. Spanish‑speaking, female, and foreign‑born participants showed lower...

By RAND Blog/Analysis
Reckoning With State and Federal Cuts, Los Angeles Safety-Net Clinics Push for a New Tax
NewsMar 16, 2026

Reckoning With State and Federal Cuts, Los Angeles Safety-Net Clinics Push for a New Tax

Los Angeles safety‑net providers, led by St. John’s Community Health, face a potential one‑third drop in their $240 million annual budget as federal Medicaid cuts and state budget tightening bite. To plug the shortfall, a coalition of clinics and advocates is...

By KFF Health News
340B: When the Safest Move Can Feel Like No Move at All. Why ‘Waiting’ Is No Longer a Viable Strategy.
NewsMar 16, 2026

340B: When the Safest Move Can Feel Like No Move at All. Why ‘Waiting’ Is No Longer a Viable Strategy.

The article warns that passive waiting on 340B policy shifts is no longer safe, as it hands compliance risk and margin pressure to regulators and competitors. Manufacturers must shift from guesswork to data‑driven oversight, especially by capturing claims‑level utilization across...

By PharmaVoice
Why Real-Time Data Is Becoming Central to PBM Client Retention
NewsMar 16, 2026

Why Real-Time Data Is Becoming Central to PBM Client Retention

Regulatory scrutiny and soaring drug prices are forcing pharmacy benefit managers (PBMs) to deliver real‑time data to their clients. Traditional reporting cycles of 30‑90 days leave payers reacting to problems after they occur, eroding trust and increasing churn risk. RxSense...

By Healthcare Dive (Industry Dive)
In Switching to Original Medicare, Beware of Medigap Plan Refusals
NewsMar 16, 2026

In Switching to Original Medicare, Beware of Medigap Plan Refusals

During the Medicare Advantage open enrollment period, beneficiaries can switch to Original Medicare, but obtaining a Medigap supplement may be blocked by medical underwriting. While federal law offers a six‑month guaranteed‑issue window for new Medicare Part B enrollees, most retirees lose...

By KFF Health News
State Spending Growth Benchmarks and Hospital Revenue, Hospital Prices, and Premiums
NewsMar 16, 2026

State Spending Growth Benchmarks and Hospital Revenue, Hospital Prices, and Premiums

Since 2013, nine U.S. states have introduced health‑care spending growth benchmarks, with eight states actively analyzed in a recent case‑control study covering 2015‑2025. The research compared hospital revenue, price indices, and insurance premiums against entropy‑balanced counterparts in non‑benchmark states. Overall,...

By RAND Blog/Analysis
Psilocybin Microdosing in the United States
NewsMar 16, 2026

Psilocybin Microdosing in the United States

A nationally representative survey conducted Dec 2023‑Jan 2024 found that 12.1% of U.S. adults have ever used psilocybin, and 26.5% of those users microdosed on their last occasion. Among the 3.1% who used psilocybin in the past year, nearly half (46.9%) reported...

By RAND Blog/Analysis
Senators, Health Experts Alarmed over Sharp Rise in Number of E-Cigs, Vape Users Among Filipino Youth
NewsMar 16, 2026

Senators, Health Experts Alarmed over Sharp Rise in Number of E-Cigs, Vape Users Among Filipino Youth

A Senate hearing highlighted a dramatic increase in e‑cigarette use among Filipino teenagers, rising from about 37,500 users in 2021 to more than 423,000 in 2023. Health experts reported that youths as young as 13 are experimenting with flavored vapes...

By Manila Bulletin – Business
'Concerning Reading' | NHS Staff Report Increasing Pressure on Staffing Levels, Wellbeing & Engagement
NewsMar 16, 2026

'Concerning Reading' | NHS Staff Report Increasing Pressure on Staffing Levels, Wellbeing & Engagement

The 2025 NHS Staff Survey of more than 760,000 employees shows only 33 percent feel there are enough staff, a slight dip from 34 percent in 2024 but still higher than 27 percent in 2021. Burnout rose modestly to 31 percent and work frustration...

By HR Grapevine
Roche Receives CE Mark for Its Elecsys ApoE4 Test to Support Blood-Based Alzheimer’s Biomarker Testing
NewsMar 16, 2026

Roche Receives CE Mark for Its Elecsys ApoE4 Test to Support Blood-Based Alzheimer’s Biomarker Testing

Roche has secured CE Mark approval for its Elecsys ApoE4 in‑vitro diagnostic immunoassay, a blood‑based test that detects the ApoE4 gene variant linked to Alzheimer’s disease. In a validation study of 607 patients with cognitive complaints, the assay achieved 100%...

By PharmaShots
Clinical Safety of Large Language Models in Oral Cancer–Related Patient Communication: A Longitudinal Study
NewsMar 16, 2026

Clinical Safety of Large Language Models in Oral Cancer–Related Patient Communication: A Longitudinal Study

A prospective longitudinal study compared Google Gemini Pro and xAI Grok‑1 on Turkish oral‑cancer patient queries over seven days. Both models delivered moderate‑to‑high scientific accuracy (Gemini 3.52, Grok 3.39) and high referral safety (90‑92%). Grok generated longer sentences but readability...

By Research Square – News/Updates
Clinical, Operational, and Economic Evaluation of Point-of-Care X-Ray Use in Outbreak Response in Nigeria: A Cross-Sectional Mixed-Methods Study
NewsMar 16, 2026

Clinical, Operational, and Economic Evaluation of Point-of-Care X-Ray Use in Outbreak Response in Nigeria: A Cross-Sectional Mixed-Methods Study

A cross‑sectional mixed‑methods study of 327 Nigerian healthcare professionals evaluated point‑of‑care (POC) X‑ray use during outbreak response. Respondents rated POC X‑ray highly for rapid screening (mean 4.6/5), differential diagnosis and severity assessment. Multivariable analysis showed physicians, field workers, greater experience...

By Research Square – News/Updates
Metabolic and Bariatric Surgery and Male Endocrine and Reproductive Health: A GRADE-Assessed Meta-Analysis
NewsMar 16, 2026

Metabolic and Bariatric Surgery and Male Endocrine and Reproductive Health: A GRADE-Assessed Meta-Analysis

A GRADE‑assessed meta‑analysis of 59 studies (2,401 men) shows metabolic and bariatric surgery markedly improves male endocrine function. Total testosterone rises 5‑8 nmol/L across all follow‑up intervals, while free testosterone shows significant gains after six months. Estradiol declines and SHBG increases,...

By Frontiers in Nutrition
Employers Are Buying Health Insurance Blind: It’s Time to Demand Data Transparency
NewsMar 16, 2026

Employers Are Buying Health Insurance Blind: It’s Time to Demand Data Transparency

Employers spend billions on health insurance yet lack visibility into plan performance, such as denial rates and appeal outcomes. Premiums continue outpacing wage growth while coverage rules increasingly dictate whether care is delivered. Insurers have resisted sharing operational data, leaving...

By HIT Consultant
Ten Killed in Fire at India Hospital Intensive Care Unit
NewsMar 16, 2026

Ten Killed in Fire at India Hospital Intensive Care Unit

Ten patients were killed and 11 staff injured when a fire erupted in the trauma‑care ICU of SCB Medical College and Hospital in Cuttack, Odisha. The blaze, likely sparked by an electrical short circuit, spread to an adjoining ICU and...

By BBC – World Asia (macro/policy affecting markets)
Dual Tasks Impact Gait, Stability in Older Adults
NewsMar 16, 2026

Dual Tasks Impact Gait, Stability in Older Adults

A recent study examined how dual‑task conditions—simultaneously walking and performing a cognitive task—alter gait and postural stability in adults over 65. Participants showed a 15% reduction in walking speed and a 20% increase in stride variability when multitasking. Balance assessments...

By Bioengineer.org
Inter‐Crystal Spacing of Implantable Polymeric Surfaces as a Key Suppressor of Microbial Adhesion.
NewsMar 16, 2026

Inter‐Crystal Spacing of Implantable Polymeric Surfaces as a Key Suppressor of Microbial Adhesion.

The researchers demonstrated that repeated shape‑memory polymer (SMP) recovery aligns surface crystals and compresses amorphous gaps, dramatically reducing bacterial adhesion. In vitro assays with Escherichia coli, Pseudomonas aeruginosa and Staphylococcus aureus showed progressive detachment as programming cycles increased. An SMP...

By Small (Wiley)
Overseas Staff Are Vital to Health of NHS, Finds Inquiry
NewsMar 16, 2026

Overseas Staff Are Vital to Health of NHS, Finds Inquiry

A parliamentary inquiry found that one‑third of NHS staff are internationally trained, saving the UK roughly £14 bn in training costs. In 2025, about 25% of nurses on the register were foreign‑educated, and half of new nursing hires in 2023‑24 came...

By Personnel Today
Can Hormone Therapy for Menopause Improve Weight Loss, Bone Health?
NewsMar 16, 2026

Can Hormone Therapy for Menopause Improve Weight Loss, Bone Health?

Recent research indicates hormone replacement therapy (HRT) can enhance weight loss when combined with tirzepatide and lower osteoporosis risk when started early in menopause. A meta‑review of over one million women found no safety signals, prompting the FDA to drop...

By Medical News Today
Denali’s Hunter Syndrome Candidate in the Spotlight After REGENXBIO Rejection
NewsMar 16, 2026

Denali’s Hunter Syndrome Candidate in the Spotlight After REGENXBIO Rejection

REGENXBIO's gene therapy RGX‑121 for Hunter syndrome received an FDA Complete Response Letter, with the agency flagging patient‑eligibility definitions, natural‑history control comparability, and the surrogate endpoint as problematic. The rejection redirects focus to Denali Therapeutics, whose enzyme‑replacement candidate tividenofusp alfa...

By BioSpace
Critical Need to Have Support Systems for Doctors
NewsMar 16, 2026

Critical Need to Have Support Systems for Doctors

A Malaysian study in the ASEAN Journal of Psychiatry reveals that one in four doctors experience burnout, while nearly half report depression symptoms and about 60% suffer significant anxiety. Recent tragic deaths of two trainee doctors have heightened awareness of...

By New Straits Times (Malaysia) – Business